Author

C. Hugo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Blazquez-Navarro· 2 shared B. Sawitzki· 2 shared C. Bauer· 2 shared M. Or-Guil· 2 shared N. Babel· 2 shared N. Wittenbrink· 2 shared O. Thomusch· 2 shared P. Reinke· 2 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. Blazquez-Navarro

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models

A. Petcherski, M. Sharma, S. Satta, M. Daskou, H. Vasilopoulos, C. Hugo, E. Ritou, B. J. Dillon, E. Fung, G. Garcia, C. Scafoglio, A. Purkayastha, B. Gomperts, G. A. Fishbein, V. Arumugaswami, , T. Kelesidis

Mitoquinone mesylate shows antiviral and anti-inflammatory effects against SARS-CoV-2 in preclinical models.

bioRxiv · Feb 22, 2022 · PreprintMicrobiology

Sex-associated differences in cytomegalovirus prevention: Prophylactic strategy is associated with a strong kidney function impairment in female renal transplant patients

A. Blazquez-Navarro, C. Dang-Heine, C. Bauer, N. Wittenbrink, K. Wolk, R. Sabat, O. Witzke, T. H. Westhoff, B. Sawitzki, P. Reinke, O. Thomusch, C. Hugo, N. Babel, M. Or-Guil

This study compares prophylactic and pre-emptive strategies for preventing CMV syndrome in renal transplant patients, finding that the prophylactic strategy impairs kidney function in females.

bioRxiv · Jan 30, 2020Pharmacology & Toxicology

A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection

N. Wittenbrink, S. Herrmann, A. Blazquez-Navarro, C. Bauer, E. Lindberg, P. Reinke, B. Sawitzki, O. Thomusch, C. Hugo, N. Babel, H. Seitz, M. Or-Guil

This paper develops a novel method using HLA class 1 single antigen bead signatures to predict acute cellular rejection risk pre-transplant with high accuracy.

bioRxiv · Oct 5, 2018Immunology